Erste Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Erste Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-14,470	Closed	-$4.58M	–	583
2023 Q4	$4.58M	Buy	14,470 +5,000	+53%	+$972K	0.07%	233
2023 Q3	$1.61M	Buy	9,470 +2,400	+34%	+$451K	0.03%	294
2023 Q2	$1.53M	Hold	7,070	–	–	0.03%	314
2023 Q1	$1.27M	Hold	7,070	–	–	0.02%	326
2022 Q4	$1.37M	Hold	7,070	–	–	0.03%	313
2022 Q3	$1.59M	Hold	7,070	–	–	0.04%	306
2022 Q2	$884K	Hold	7,070	–	–	0.02%	371
2022 Q1	$870K	Hold	7,070	–	–	0.02%	373
2021 Q4	$932K	Hold	7,070	–	–	0.02%	362
2021 Q3	$840K	Hold	7,070	–	–	0.02%	351
2021 Q2	$787K	Buy	+7,070	New	+$826K	0.02%	368

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Erste Asset Management's KRTX Position: Q1 2024 in Review

Erste Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 14,470 shares — an estimated $4.58M sold.

Erste Asset Management first reported a position in KRTX in Q2 2021 and held it in 11 quarters. The position peaked at $4.58M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Erste Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Erste Asset Management sold 14,470 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $4.58M.
Erste Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q2 2021 and held it in 11 quarters.
Erste Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $4.58M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Erste Asset Management's 13F filing for Q1 2024, filed 26 Nov 2024.